id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
aiua-11509	Bapir, Rawa; Bhatti, Kamran Hassan; Eliwa, Ahmed; García-Perdomo, Herney Andrés; Gherabi, Nazim; Hennessey, Derek; Magri, Vittorio; Mourmouris, Panagiotis; Ouattara, Adama; Perletti, Gianpaolo; Philipraj, Joseph; Stamatiou, Konstantinos; Tolani, Musliu Adetola; Tzelves, Lazaros; Anker, Stefan D.; Trinchieri, Alberto; Buchholz, Noor	Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis	2023	8	.pdf	application/pdf	6072	349	48	Materials and methods: We conducted a systematic review and meta-analysis by searching PubMed and EMBASE for random- ized controlled trials (RCTs) reporting urogenital adverse effects in non-diabetic patients treated with SGLT2 inhibitors. Compared to placebo, SGLT2 inhibitors were associated with increased odds of genital infections (OR 3.01, 95% CI: 1.93- 4.68, 9 series, 7326 participants, Z = 5.74, p < 0.0001, I2 = 0%) as well as urinary tract infections (OR 1.33, 95% CI: 1.13-1.57, Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors.	cache/aiua-11509.pdf	txt/aiua-11509.txt